These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 24729987)
21. [Iron in the era of molecular biology]. Deugnier Y; Moirand R; Brissot P; David V Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274 [TBL] [Abstract][Full Text] [Related]
22. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study. McLaren CE; Barton JC; Eckfeldt JH; McLaren GD; Acton RT; Adams PC; Henkin LF; Gordeuk VR; Vulpe CD; Harris EL; Harrison BW; Reiss JA; Snively BM Am J Hematol; 2010 Feb; 85(2):101-5. PubMed ID: 20095037 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait. Garewal G; Das R; Ahluwalia J; Marwaha RK Eur J Haematol; 2005 Apr; 74(4):333-6. PubMed ID: 15777346 [TBL] [Abstract][Full Text] [Related]
24. Status of HFE mutation in thalassemia syndromes in north India. Agarwal S; Tewari D; Arya V; Moorchung N; Tripathi R; Chaudhuri G; Pradhan M Ann Hematol; 2007 Jul; 86(7):483-5. PubMed ID: 17401564 [TBL] [Abstract][Full Text] [Related]
25. Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overload. Fargion S; Valenti L; Fracanzani AL Hepatology; 2010 Apr; 51(4):1119-21. PubMed ID: 20373367 [No Abstract] [Full Text] [Related]
26. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P; N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186 [TBL] [Abstract][Full Text] [Related]
27. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation. Distante S Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242 [No Abstract] [Full Text] [Related]
28. Iron overload and chronic hepatitis C: the role of HFE gene mutations. García Buey L; González Mateos F Rev Esp Enferm Dig; 2003 Dec; 95(12):819-28. PubMed ID: 14972003 [No Abstract] [Full Text] [Related]
29. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population. Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086 [TBL] [Abstract][Full Text] [Related]
30. Assessment of HFE mutations in patients with iron overload. Bittencourt PL Sao Paulo Med J; 2007 Jan; 125(1):65-7. PubMed ID: 17505690 [No Abstract] [Full Text] [Related]
31. Hemochromatosis gene (HFE) mutations in South East Asia: a potential for iron overload. Pointon JJ; Viprakasit V; Miles KL; Livesey KJ; Steiner M; O'Riordan S; Hien TT; Merryweather-Clarke AT; Robson KJ Blood Cells Mol Dis; 2003; 30(3):302-6. PubMed ID: 12737949 [TBL] [Abstract][Full Text] [Related]
32. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814 [TBL] [Abstract][Full Text] [Related]
33. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis. Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080 [TBL] [Abstract][Full Text] [Related]
34. Mutant HFE genotype leads to significant iron overload in patients with liver diseases from western Romania. Neghina AM; Anghel A; Sporea I; Popescu A; Neghina R; Collins A; Thorstensen K J Appl Genet; 2009; 50(2):173-6. PubMed ID: 19433916 [TBL] [Abstract][Full Text] [Related]
35. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000). Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorder. Viprakasit V; Vathesathokit P; Chinchang W; Tachavanich K; Pung-Amritt P; Wimhurst VL; Yenchitsomanus PT; Merryweather-Clarke AT; Tanphaichitr VS Eur J Haematol; 2004 Jul; 73(1):43-9. PubMed ID: 15182337 [TBL] [Abstract][Full Text] [Related]
37. Obscure pathogenesis of primary iron overload in Indians warrants more focused research. Das R; Chandak GR Indian J Gastroenterol; 2011 Jul; 30(4):154-5. PubMed ID: 21847604 [No Abstract] [Full Text] [Related]
38. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants. Acton RT; Barton JC; Leiendecker-Foster C; Zaun C; McLaren CE; Eckfeldt JH Blood Cells Mol Dis; 2010 Apr; 44(4):252-6. PubMed ID: 20178892 [TBL] [Abstract][Full Text] [Related]
39. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390 [TBL] [Abstract][Full Text] [Related]
40. Hemochromatosis genotypes and risk of iron overload--a meta-analysis. Neghina AM; Anghel A Ann Epidemiol; 2011 Jan; 21(1):1-14. PubMed ID: 20800508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]